{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:42:36Z","timestamp":1793479356020,"version":"4.5.0"},"reference-count":37,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>TGF-\u03b2\u2013activated kinase 1 (TAK1), a member of the MAPK kinase family, plays a key role in B-cell growth and development. In the present study, we examined the potential role of TAK1 as a therapeutic target for lymphoma. Here, we show that the active phosphorylated form of TAK1 is abundantly expressed in a panel of lymphoma cell lines, including mantle cell, anaplastic large cell, and Hodgkin lymphoma cell lines. Silencing TAK1 expression via the use of siRNA inhibited the activation of NF-\u03baB and p38 and induced apoptosis in lymphoma cell lines. Moreover, submicromolar concentrations of AZ-TAK1, a novel ATP-competitive small molecule inhibitor of TAK1, dephosphorylated TAK1, p38, and I\u03baB-\u03b1 in lymphoma cell lines. These molecular events were associated with the release of cytochrome c into the cytosol, down-regulation of X-linked inhibitor of apoptosis, activation of caspase 9, and induction of apoptosis. We also demonstrate that primary lymphoma cells express TAK1 and pTAK1 and were sensitive to AZ-TAK1\u2013mediated cell death. Collectively, our data demonstrate an essential role for TAK1 in regulating critical survival mechanisms in lymphoma and suggest that it may serve as a therapeutic target.<\/jats:p>","DOI":"10.1182\/blood-2011-07-369397","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T06:09:07Z","timestamp":1338444547000},"page":"347-355","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":55,"title":["Essential role of TAK1 in regulating mantle cell lymphoma survival"],"prefix":"10.1182","volume":"120","author":[{"given":"Daniela","family":"Buglio","sequence":"first","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeetha","family":"Palakurthi","sequence":"additional","affiliation":[{"name":"AstraZeneca R&D Boston, Waltham, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Byth","sequence":"additional","affiliation":[{"name":"AstraZeneca R&D Boston, Waltham, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorin","family":"Toader","sequence":"additional","affiliation":[{"name":"AstraZeneca R&D Boston, Waltham, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Saeh","sequence":"additional","affiliation":[{"name":"AstraZeneca R&D Boston, Waltham, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattva S.","family":"Neelapu","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Younes","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5244","key":"2019111808062034300_B1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1126\/science.270.5244.2008","article-title":"Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction.","volume":"270","author":"Yamaguchi","year":"1995","journal-title":"Science"},{"issue":"5","key":"2019111808062034300_B2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.biocel.2009.12.023","article-title":"The TAK1-TRAF6 signalling pathway.","volume":"42","author":"Landstr\u00f6m","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"2019111808062034300_B3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-065X.2009.00836.x","article-title":"Comprehending the complex connection between PKCbeta, TAK1, and IKK in BCR signaling.","volume":"232","author":"Shinohara","year":"2009","journal-title":"Immunol Rev"},{"issue":"9","key":"2019111808062034300_B4","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1182\/blood-2008-08-176057","article-title":"A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation.","volume":"113","author":"Schuman","year":"2009","journal-title":"Blood"},{"issue":"18","key":"2019111808062034300_B5","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood-2010-02-269605","article-title":"In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells.","volume":"116","author":"Courties","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2019111808062034300_B6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ni1255","article-title":"Essential function for the kinase TAK1 in innate and adaptive immune responses.","volume":"6","author":"Sato","year":"2005","journal-title":"Nat Immunol"},{"issue":"5","key":"2019111808062034300_B7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.cdd.4401869","article-title":"Ubiquitin, TAK1 and IKK: is there a connection?","volume":"13","author":"Chen","year":"2006","journal-title":"Cell Death Differ"},{"issue":"31","key":"2019111808062034300_B8","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1073\/pnas.0603089103","article-title":"Essential role of TAK1 in thymocyte development and activation.","volume":"103","author":"Liu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111808062034300_B9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ni1355","article-title":"The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function.","volume":"7","author":"Wan","year":"2006","journal-title":"Nat Immunol"},{"key":"2019111808062034300_B10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-7-40","article-title":"Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma.","volume":"7","author":"Yang","year":"2008","journal-title":"Mol Cancer"},{"issue":"1-2","key":"2019111808062034300_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428199309148499","article-title":"Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines.","volume":"9","author":"Drexler","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"2019111808062034300_B12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","article-title":"Characterization of 4 mantle cell lymphoma cell lines.","volume":"127","author":"Amin","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2019111808062034300_B13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-4608(02)00589-7","article-title":"Molecular cytogenetic aberrations in CD30+ anaplastic large cell lymphoma cell lines.","volume":"138","author":"Gogusev","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"issue":"3-4","key":"2019111808062034300_B14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/10428190109057942","article-title":"Establishment of a human cell line (SKI-DLCL-1) with a t(1;14)(q21;q32) translocation from the ascites of a patient with diffuse large cell lymphoma.","volume":"40","author":"Goy","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2019111808062034300_B15","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1182\/blood.V73.8.2155.2155","article-title":"Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis.","volume":"73","author":"Morgan","year":"1989","journal-title":"Blood"},{"issue":"8","key":"2019111808062034300_B16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.leukres.2003.12.008","article-title":"Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta\/lambda type immunoglobulin.","volume":"28","author":"Matsuo","year":"2004","journal-title":"Leuk Res"},{"issue":"4","key":"2019111808062034300_B17","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood-2008-01-133769","article-title":"Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.","volume":"112","author":"Buglio","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111808062034300_B18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood-2002-11-3507","article-title":"MEK\/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival.","volume":"102","author":"Zheng","year":"2003","journal-title":"Blood"},{"key":"2019111808062034300_B19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/1078-0432.CCR-05-1194","article-title":"Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.","volume":"12","author":"Georgakis","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2019111808062034300_B20","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-08-1808","article-title":"Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma.","volume":"69","author":"Singh","year":"2009","journal-title":"Cancer Res"},{"issue":"10","key":"2019111808062034300_B21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/modpathol.2009.98","article-title":"Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma.","volume":"22","author":"Kim","year":"2009","journal-title":"Mod Pathol"},{"issue":"7","key":"2019111808062034300_B22","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"issue":"15","key":"2019111808062034300_B23","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","article-title":"An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.","volume":"68","author":"Stemke-Hale","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"2019111808062034300_B24","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1074\/jbc.275.10.7359","article-title":"TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop.","volume":"275","author":"Kishimoto","year":"2000","journal-title":"J Biol Chem"},{"issue":"8","key":"2019111808062034300_B25","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1074\/jbc.M407537200","article-title":"Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2.","volume":"280","author":"Singhirunnusorn","year":"2005","journal-title":"J Biol Chem"},{"issue":"7247","key":"2019111808062034300_B26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"issue":"18","key":"2019111808062034300_B27","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1158\/1078-0432.CCR-10-1664","article-title":"X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise.","volume":"16","author":"Kashkar","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2019111808062034300_B28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood-2007-04-085480","article-title":"Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.","volume":"111","author":"Cillessen","year":"2008","journal-title":"Blood"},{"issue":"7","key":"2019111808062034300_B29","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1182\/blood-2004-07-2716","article-title":"Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.","volume":"105","author":"Muris","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111808062034300_B30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.20021279","article-title":"XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells.","volume":"198","author":"Kashkar","year":"2003","journal-title":"J Exp Med"},{"issue":"8","key":"2019111808062034300_B31","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s10495-007-0067-7","article-title":"Smac\/DIABLO is required for effector caspase activation during apoptosis in human cells.","volume":"12","author":"Rajalingam","year":"2007","journal-title":"Apoptosis"},{"issue":"1","key":"2019111808062034300_B32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood-2007-04-085480","article-title":"Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.","volume":"111","author":"Cillessen","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111808062034300_B33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/CAD.0b013e32832ced78","article-title":"Smac mimetics as new cancer therapeutics.","volume":"20","author":"Chen","year":"2009","journal-title":"Anticancer Drugs"},{"issue":"7","key":"2019111808062034300_B34","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1084\/jem.20080297","article-title":"TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice.","volume":"205","author":"Tang","year":"2008","journal-title":"J Exp Med"},{"issue":"3","key":"2019111808062034300_B35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.2008.07484.x","article-title":"The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas.","volume":"144","author":"Abramson","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111808062034300_B36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1078-0432.CCR-08-0132","article-title":"Heat shock protein 90 as a drug target: some like it hot.","volume":"15","author":"Banerji","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2019111808062034300_B37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/156800908785699379","article-title":"The heat shock protein 90 chaperone complex: an evolving therapeutic target.","volume":"8","author":"Barginear","year":"2008","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/2\/347\/1359995\/zh802812000347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/2\/347\/1359995\/zh802812000347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T13:54:35Z","timestamp":1642341275000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/2\/347\/30391\/Essential-role-of-TAK1-in-regulating-mantle-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,12]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,7,12]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-07-369397","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,12]]}}}